Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science
Former senior agency officials say Hahn prioritized politics in authorizing COVID-19 convalescent plasma
FDA Commissioner Stephen Hahn prioritized politics in his decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19, say former senior agency officials.
FDA Commissioner Stephen Hahn’s decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19 have put politics ahead of science, former senior FDA officials told BioCentury.
“At this moment in time, the FDA can no longer call itself an independent and science-based regulatory agency,” Luciana Borio, former acting FDA chief scientist, told BioCentury.
Borio, who served in the Trump administration as the National Security Council’s